Kilroy Realty Announces Dates for First Quarter 2024 Earnings Release and Conference Call

Kilroy Realty Corporation (NYSE: KRC, "Kilroy") announced today it will release first quarter 2024 financial results after the market closes on Thursday, May 2, 2024. The company will hold a conference call to discuss the results at 9:00 a.m. PT / 12:00 p.m. ET on Friday, May 3, 2024.

To participate and obtain conference call dial-in details, register by using the following link:

https://www.netroadshow.com/events/login?show=7488a962&confId=5818 ...

This call will be broadcast live over the Internet and can be accessed on the Investor Relations section of Kilroy Realty’s website at https://investors.kilroyrealty.com/shareholders/investor-events/defaul ....

A replay will also be available beginning May 3, 2024 through May 10, 2024, by dialing [phone] and entering access code 591632. International callers should dial [phone] and enter the same access code.

About Kilroy Realty Corporation

Kilroy Realty Corporation (NYSE: KRC, the “Company”, “Kilroy”) is a leading U.S. landlord and developer, with operations in San Diego, Greater Los Angeles, the San Francisco Bay Area, Greater Seattle and Austin. The Company has earned global recognition for sustainability, building operations, innovation and design. As a pioneer and innovator in the creation of a more sustainable real estate industry, the Company’s approach to modern business environments helps drive creativity and productivity for some of the world’s leading technology, entertainment, life science and business services companies.

The Company is a publicly traded real estate investment trust (“REIT”) and member of the S&P MidCap 400 Index with more than seven decades of experience developing, acquiring and managing office, life science and mixed-use projects.

As of December 31, 2023, Kilroy’s stabilized portfolio totaled approximately 17.0 million square feet of primarily office and life science space that was 85.0% occupied and 86.4% leased. The Company also had approximately 1,000 residential units in Hollywood and San Diego, which had a quarterly average occupancy of 92.5%. In addition, the Company had two in-process life science redevelopment projects totaling approximately 100,000 square feet with total estimated redevelopment costs of $80.0 million and one approximately 875,000 square foot in-process development project with a total estimated investment of $1.0 billion.